Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
INCY
#499
Incyte Corporation - Common Stock
127.5
9
USD
+0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.06%
Monthly Change
+6.13%
6 month change
+29.56%
Year Change
+48.50%
Previous Close
125.0
1
Open
127.3
0
Low
126.8
9
High
127.7
1
Volume
237
Markets
US Stock Market
Healthcare
Biotechnology
INCY
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Q2, 26
Current
Key stats
Total common shares outstanding
193.57 M
195.28 M
196.32 M
199.01 M
199.78 M
202.7 M
202.7 M
Valuation ratios
Enterprise value
9.78 B
11.34 B
14.2 B
16.56 B
15.34 B
19 B
21.97 B
Price to earnings ratio
302.75
15.91
14.5
15.41
13.29
14.44
16.31
Price to sales ratio
2.88
3.04
3.55
3.86
3.54
—
—
Price to cash flow ratio
28.8
13.71
13.78
14.02
12.56
11.22
12.67
Price to book ratio
0.93
0.95
1.07
3.84
0.97
1.06
1.2
Enterprise value to EBITDA ratio
37
8.91
9.03
10.3
9
—
—
Profitability ratios
Return on assets %
0.03
0.07
0.07
0.04
0.04
0.07
0.07
Return on equity %
0.04
0.1
0.09
0.06
0.05
0.09
0.09
Return on invested capital %
22.96
55.62
56.5
38.38
41.09
78.54
78.54
Gross margin %
93.05
93.52
92.75
91.96
91.79
93.73
93.73
Operating margin %
19.49
43.63
32.47
22.29
23.66
41.69
41.69
EBITDA margin %
21.61
45.51
34.23
23.88
25.53
—
—
Net margin %
15.03
33.32
31.05
19.86
23.83
34.98
34.98
Liquidity ratios
Quick ratio
2
2.78
3.13
3.25
3.6
4.51
4.51
Current ratio
2.04
2.85
3.2
3.32
3.68
4.59
4.59
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.19
0.21
0.22
0.23
0.18
0.22
0.22
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.34
0.23
2.78
2.71
1.79
2.83
10.1
EBIT per share
1.04
2.67
2.2
1.67
1.46
3.36
8.69
EBITDA per share
1.15
2.78
2.32
1.79
1.57
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
9.8
9.84
12.19
15.44
16.73
19.18
19.18
Net current asset value per share
17.7
18.33
21.24
25.03
26.52
29.02
29.02
Tangible book value per share
18.5
20.99
23.09
25.75
27.19
29.41
29.41
Working capital per share
9.02
11.9
14.59
17.48
19.31
22.7
22.7
Book value per share
18.5
20.99
23.09
25.75
27.19
30.55
30.55
News
Incyte Corporation: Why Jakafi Is No Longer The Real Story Here (NASDAQ:INCY)
Oil And Gas Giants Valero, Equinor Pop To New Highs, Among New Names On Best Stock Lists
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
Software Giant Microsoft Hits 52-Week High, Leads 13 Hot Prospects Onto Best Stocks Screens
Why Is uniQure (QURE) Up 17.5% Since Last Earnings Report?
Incyte (INCY) Up 0.8% Since Last Earnings Report: Can It Continue?
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade) (NASDAQ:TGTX)
Interactive Brokers Pops To New High, Leads 13 Hot Prospects Onto Best Stock Lists
Don't Sleep On Software
Wealth Manager SEI Hits Record High, Leads 13 Newcomers To Best Stock Lists
Can Spyre's SPY772 HS Study Broaden Its Growth Story Beyond Core IBD?
Prelude Therapeutics: A Prognosis After Year Long Rally (NASDAQ:PRLD)